First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors
Clinical trial NCT06622486 · RECRUITING
Trial details
- NCT number
- NCT06622486
- Sponsor
- Egle Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-27
- Primary completion
- 2027-01-23
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.